Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
Volpato M, Ingram N, Perry SL, Spencer J, Race AD, Marshall C, Hutchinson JM, Nicolaou A, Loadman PM, Coletta PL, Hull MA. Volpato M, et al. Among authors: perry sl. Cancer Chemother Pharmacol. 2021 Feb;87(2):173-184. doi: 10.1007/s00280-020-04157-2. Epub 2020 Oct 11. Cancer Chemother Pharmacol. 2021. PMID: 33040178 Free PMC article.
The omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility.
Hawcroft G, Volpato M, Marston G, Ingram N, Perry SL, Cockbain AJ, Race AD, Munarini A, Belluzzi A, Loadman PM, Coletta PL, Hull MA. Hawcroft G, et al. Among authors: perry sl. Br J Pharmacol. 2012 Jul;166(5):1724-37. doi: 10.1111/j.1476-5381.2012.01882.x. Br J Pharmacol. 2012. PMID: 22300262 Free PMC article.
Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observations.
Ingram N, Northwood EL, Perry SL, Marston G, Snowden H, Taylor JC, Scott N, Bishop DT, Coletta PL, Hull MA. Ingram N, et al. Among authors: perry sl. Carcinogenesis. 2013 Oct;34(10):2341-9. doi: 10.1093/carcin/bgt222. Epub 2013 Jun 19. Carcinogenesis. 2013. PMID: 23784081 Free PMC article.
Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis.
Volpato M, Perry SL, Marston G, Ingram N, Cockbain AJ, Burghel H, Mann J, Lowes D, Wilson E, Droop A, Randerson-Moor J, Coletta PL, Hull MA. Volpato M, et al. Among authors: perry sl. Oncotarget. 2016 May 10;7(19):28139-50. doi: 10.18632/oncotarget.8579. Oncotarget. 2016. PMID: 27058904 Free PMC article. Clinical Trial.
Correction to: Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega‑3 polyunsaturated fatty acid eicosapentaenoic acid.
Volpato M, Ingram N, Perry SL, Spencer J, Race AD, Marshall C, Hutchinson JM, Nicolaou A, Loadman PM, Coletta PL, Hull MA. Volpato M, et al. Among authors: perry sl. Cancer Chemother Pharmacol. 2021 Jun;87(6):879-880. doi: 10.1007/s00280-020-04194-x. Cancer Chemother Pharmacol. 2021. PMID: 33200275 Free PMC article. No abstract available.
137 results